eicosapentaenoic acid ethyl ester has been researched along with Weight Loss in 1 studies
Weight Loss: Decrease in existing BODY WEIGHT.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Recent reports suggest that weight loss in cachectic cancer patients may be inhibited by supplementation of the n-3 fatty acid eicosapentaenoic acid (20:5n-3; EPA), presumably due to inhibition of lipolysis." | 5.09 | Eicosapentaenoic acid ethyl ester supplementation in cachectic cancer patients and healthy subjects: effects on lipolysis and lipid oxidation. ( Dagnelie, PC; Swart, GR; Van den Berg, JW; Van der Gaast, A; Wattimena, JL; Wilson, JH; Zuijdgeest-Van Leeuwen, SD, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zuijdgeest-Van Leeuwen, SD | 1 |
| Dagnelie, PC | 1 |
| Wattimena, JL | 1 |
| Van den Berg, JW | 1 |
| Van der Gaast, A | 1 |
| Swart, GR | 1 |
| Wilson, JH | 1 |
1 trial available for eicosapentaenoic acid ethyl ester and Weight Loss
| Article | Year |
|---|---|
Eicosapentaenoic acid ethyl ester supplementation in cachectic cancer patients and healthy subjects: effects on lipolysis and lipid oxidation.
Topics: Aged; Cachexia; Double-Blind Method; Eicosapentaenoic Acid; Female; Humans; Lipid Peroxidation; Lipo | 2000 |